Katsuaki Maehara, Director of Medical Education Colleagues, posted on X:
“Immunotherapy trials in resectable NSCLC.
Updated clinical data as of January, 2025.
KEYNOTE-671 – 4 year update.”
Katsuaki Maehara, Director of Medical Education Colleagues, posted on X:
“Immunotherapy trials in resectable NSCLC.
Updated clinical data as of January, 2025.
KEYNOTE-671 – 4 year update.”